Evidence map›Paper›PMID 37096168›Full record

ArticleClinical case reports2023

Sclerosing epithelioid fibrosarcoma of the foot: A case report.

Alex Mremi, Adnan Sadiq, Gregory Goodluck, Jay Lodhia

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. International journal of molecular sciences · 2024
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Alex MremiDepartment of Pathology Kilimanjaro Christian Medical Centre Moshi Tanzania.ORCID https://orcid.org/0000-0001-7226-0168
Adnan SadiqFaculty of Medicine Kilimanjaro Christian Medical University College Moshi Tanzania.
Gregory GoodluckDepartment of General Surgery Kilimanjaro Christian Medical Centre Moshi Tanzania.
Jay LodhiaFaculty of Medicine Kilimanjaro Christian Medical University College Moshi Tanzania.ORCID https://orcid.org/0000-0002-3373-5762
Kilimanjaro Christian Medical Centre · TZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sclerosing epithelioid fibrosarcoma (SEF) is a rare and distinctive variant of fibrosarcoma. To date, about 100 cases only have been documented. Histopathologically, it resembles a variety of benign, pseudosarcomatous and other malignancies. Early diagnosis and treatment are vital for improving the treatment outcomes.

Indexed as

case reportdiagnosisfootsclerosing epithelioid fibrosarcomaTanzania

Identifiers

PMID37096168
PMCPMC10122097
OpenAlexW4366769874

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.